SCS Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$961K Sell
1,953
-186
-9% -$101K 0.01% 279
2025
Q4
$1.24M Buy
2,139
+85
+4% +$48.1K 0.01% 261
2025
Q3
$997K Sell
2,054
-117
-5% -$54.5K 0.01% 286
2025
Q2
$881K Sell
2,171
-528
-20% -$221K 0.01% 307
2025
Q1
$1.34M Buy
+2,699
New +$1.46M 0.02% 234

Other funds holding TMO

SCS Capital Management's TMO Position: Q1 2026 in Review

SCS Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 8.7% in Q1 2026, selling an estimated $101K and leaving 1,953 shares worth $961K. The position accounts for 0.01% of the portfolio, ranked #279.

SCS Capital Management first reported a position in TMO in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.34M in Q1 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • SCS Capital Management held 1,953 shares of Thermo Fisher Scientific worth $961K as of Q1 2026.
  • SCS Capital Management sold 186 Thermo Fisher Scientific shares in Q1 2026, an estimated $101K.
  • Thermo Fisher Scientific made up 0.01% of SCS Capital Management's portfolio in Q1 2026, its #279 holding.
  • SCS Capital Management first reported a position in Thermo Fisher Scientific in Q1 2025 and has held it in 5 quarters since.
  • SCS Capital Management's Thermo Fisher Scientific position peaked at $1.34M in Q1 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on SCS Capital Management's 13F filing for Q1 2026, filed 11 May 2026.